In conjunction with the relentless growth of cardiometabolic diseases, obesity is now a worldwide epidemic (Lingvay et al., 2024). Bariatric surgery remains the most effective obesity treatment, largely mediated through rewiring hormonal and neural regulation (Lingvay et al., 2024). In the last decade, pharmacotherapy has been made available for the treatment by harnessing these key hormonal alterations (Melson et al., 2024).